Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Sale of Stock [Axis] At-the-Market Offering Program [Member] Private Placement [Member] Long-Lived Tangible Asset [Axis] Research Equipment and Software [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Office Equipment [Member] Leasehold Improvements [Member] Location, Statement of Income, Balance [Axis] Research and Development Expenses [Member] Cash and Cash Equivalents [Axis] Cash [Member] Investment Type [Axis] Money Market Funds [Member] Asset Class [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Award Date [Axis] 2013 Through June 30, 2022 [Member] Legal Entity [Axis] Israeli Innovation Authority [Member] Business Combination [Axis] CardioSert Ltd [Member] Ministry of Economy [Member] Technion Research and Development Foundation Limited [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Product and Service [Axis] Device [Member] Integrated Product [Member] Securities Purchase Agreement [Member] Litigation Settlement [Member] Title and Position [Axis] Chief Executive Officer and Executives and Certain Employees [Member] Series A Preferred Investment Options [Member] Series C Preferred Investment Options [Member] Series D Preferred Investment Options [Member] Existing Preferred Investment Options [Member] Inducement Investment Options [Member] Preferred Investment Option Exercise Inducement Offers Letter [Member] Series F Preferred Investment Options [Member] Series G Preferred Investment Options [Member] Series H Preferred Investment Options [Member] Series I Preferred Investment Options [Member] Placement Agent Preferred Investment Options [Member] Class of Stock [Axis] Series E, G, H, I and Series F Preferred Investment Options [Member] The Letter Agreement [Member] Series J Preferred Investment Options [Member] Award Type [Axis] Preferred Investment Options [Member] Derivative Instrument [Axis] Second Closing [Member] Third Closing [Member] Wainwright [Member] Chief Executive Officer [Member] Management [Member] Chief Executive Officer and Other Executives [Member] CEO, Executives [Member] Certain Employees [Member] Advisors [Member] Board [Member] Plan Name [Axis] 2020 Omnibus Performance Award Plan [Member] Executives [Member] Certain Employees and Certain Board Members [Member] Employees and Directors [Member] Exercise Price Range [Axis] Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Exercise Price Five [Member] Warrant To Underwriters October 2022 [Member] Warrant To Underwriters May 2023 [Member] Warrant To Underwriters May 2023 One [Member] Warrant to Underwriters June 2023 [Member] Warrant to Underwriters June 2023 One [Member] Warrant Series E January 2024 [Member] Warrant to Underwriters January 2024 [Member] Warrant Series F June 2024 [Member] Warrant to Underwriters June 2024 [Member] Warrant To Underwriters January 2025 [Member] Warrant To Underwriters January 2025 One [Member] Warrant To Underwriters January 2025 Two [Member] Warrant to Underwriters February 2025 [Member] Warrant To Underwriters September 2025 [Member] Warrant To Underwriters September 2025 One [Member] Warrant To Underwriters September205 Two [Member] Warrant To Underwriters September2025 Three [Member] Warrant To Underwriters September 2025 Four [Member] Warrant To Underwriters September 2025 Five [Member] Warrant To Underwriters September 2025 Six [Member] Warrant To Underwriters September 2025 Seven [Member] Warrant To Underwriters September 2025 Eight [Member] Warrant to Underwriters September 2025 Nine [Member] Warrant Series J September 2025 [Member] Warrant Series J September 2025 One [Member] Warrant Series J October 2025 One [Member] Warrant Series J October 2025 Two [Member] Sales,General and Administrative Expenses [Member] Geographical [Axis] ISRAEL UNITED STATES Income Tax Authority, Name [Axis] US Tax Authority [Member] Pre 2017 [Member] Post 2017 [Member] Israel Tax Authority [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Executives and Certain Employees [Member] Executive Committee [Member] Employees [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Marketable securities Restricted cash Inventory Prepaid expenses and other current assets Total current assets Long-term assets: Restricted cash Long-term deposit Property and equipment, net Operating right-of-use assets Total assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable Lease liabilities Accrued liabilities Total current liabilities Non-current liabilities: Long-term lease liabilities Total liabilities Commitments and contingencies Shareholders’ equity: Common stock; $0.01 par value; 120,000,000 and 60,000,000 shares authorized as of December 31, 2025 and 2024, respectively; 67,158,044 and 19,399,513 shares issued and outstanding as of December 31, 2025 and 2024, respectively Additional paid-in capital Accumulated deficit Total shareholders’ equity Total liabilities and shareholders’ equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Research and development, net Sales, general and administrative Operating loss Financing income, net Other income Net loss Basic net loss per share Diluted net loss per share Basic weighted average common shares outstanding Diluted weighted average common shares outstanding Statement [Table] Statement [Line Items] Balance Balance, shares Issuance of common stock and warrants, net () Issuance of common stock and warrants net of issuance costs, shares Issuance of common stock relating to settlement agreement () Issuance of common stock relating to settlement agreement, shares Issuance of common stock under the at-the-market offering program, net () Issuance of common stock under the at-the-market offering program, net of issuance costs, shares Share-based compensation Net loss Issuance of common stock upon exercise of warrants, net () Issuance of common stock upon exercise of warrants, net, shares Exercise of options Exercise of options, shares Balance Balance, shares Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Net of issuance costs Stock issuance cost not paid Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to net cash flows used in operating activities: Depreciation of property and equipment Interest income and unrealized gains from marketable securities, net Share-based compensation Changes in assets and liabilities: Inventory Prepaid expenses and other assets Accounts payable and accrued liabilities Change in long-term deposit Insurance recovery related to legal settlement and legal expenses received in cash Legal settlement paid in cash Net cash flows used in operating activities Investing activities: Purchase of property and equipment Proceeds from maturities of marketable securities Purchase of marketable securities Proceeds from sales of marketable securities Net cash flows (used in) provided by investing activities Financing activities: Issuance of common stock and warrants, net of issuance costs Exercise of options Net cash flows provided by financing activities Increase in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of year Cash, cash equivalents and restricted cash at ending of year Supplemental disclosure of non-cash investing and financing activities: Issuance costs not paid Legal settlement settled through issuance of common stock Right-of-use assets obtained in exchange for lease liabilities Accrued bonus settled through grant of stock-option awards Deferred issuance costs Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] GENERAL Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Cash and Cash Equivalents [Abstract] CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Inventory Disclosure [Abstract] INVENTORY Prepaid Expenses And Other Current Assets PREPAID EXPENSES AND OTHER CURRENT ASSETS Leases LEASES Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Payables and Accruals [Abstract] ACCRUED LIABILITIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHARE CAPITAL Earnings Per Share [Abstract] BASIC AND DILUTED NET LOSS PER SHARE Research and Development [Abstract] RESEARCH AND DEVELOPMENT EXPENSES, NET Sales General And Administrative Expenses SALES, GENERAL AND ADMINISTRATIVE EXPENSES Segment Reporting [Abstract] SEGMENT REPORTING Related Party Transactions [Abstract] RELATED PARTIES Income Tax Disclosure [Abstract] TAXES ON INCOME Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Financial statement in U.S. dollars Use of estimates Principles of consolidation Cash and cash equivalents Restricted cash Long-term deposit Fair value of financial instruments Concentrations of credit risk Property and equipment Liabilities due to termination of employment agreements Common stock warrants Basic and diluted net loss per share Research and development expenses, net Sales, general and administrative expenses Share-based compensation Income taxes Marketable securities Leases Contingencies Government grants Inventory Segment Reporting Recently Adopted accounting pronouncements Accounting pronouncements not yet effective SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT SCHEDULE OF CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES SCHEDULE OF INVENTORIES SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS SCHEDULE OF MATURITIES OF LEASE LIABILITIES SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF ACCRUED LIABILITIES SUMMARY OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK OPTIONS OUTSTANDING SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES SCHEDULE OF STATEMENT OF OPERATION BY SEGMENT SCHEDULE OF LONG LIVED ASSETS AND OPERATING LEASE RIGHT OF USE ASSETS BY GEOGRAPHICAL AREAS SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF RECONCILIATION OF INCOME TAXES Cash equivalents and marketable securities Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, plant and equipment, useful life Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] AccountingPoliciesTable [Table] Government grants Cash and Cash Equivalent [Table] Cash and Cash Equivalents [Line Items] Total cash and cash equivalents Total marketable securities Total cash, cash equivalents and marketable securities Unrealized gains on marketable securities Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Marketable securities  Raw materials Work-in-process  Total inventory Schedule Of Prepaid Expenses And Other Current Assets Amounts due from government institutions Prepaid expenses and other receivables Total prepaid expenses and other current assets Schedule Of Maturities Of Lease Liabilities 2026 2027 2028 2029 Total future lease payments Less imputed interest Total lease liabilities Schedule Of Supplemental Information Related To Leases Operating leases weighted average remaining lease term (in years) Operating leases weighted average discount rate Finance lease principal payments Bank guarantee issued amount Operating lease cost Cash paid under operating lease agreements Cost Accumulated Depreciation Net book value Employee-related liabilities Accrued expenses Deferred income grants Other current liabilities Total Accrued Liabilities Loss Contingencies [Table] Loss Contingencies [Line Items] Revenues Grants receivable Additional grant receivable Repayment of government grants Net sales royalty percenatge Offering costs Aggregate offering Percentage of placement fee Gross proceeds from cash fee percentage Gross proceeds from management fee percentage Warrant or Right, Reason for Issuance, Description Stock issued during period, value, new issues Royalties percentage Purchase price of plaintiffs Litigation settlement amount Payment for litigation settlement Restricted common shares issued for legal settlement Liabilities current Assets current Settlement amount recovery Legal expense Non operating loss on legal settlement Insurance recovery amount Number of share issued Proceeds from Legal Settlements Accrued bonuses current and non current StockOptionActivityTable [Table] Number of stock options outstanding, Outstanding at beginning of period Weighted average exercise price, Outstanding at beginning of period Number of stock options outstanding, Granted Weighted average exercise price, Granted Number of stock options outstanding, exercised Weighted average exercise price, exercised Number of stock options outstanding, forfeitures Weighted average exercise price, forfeitures Number of stock options outstanding, Outstanding at end of period Weighted average exercise price, Outstanding at end of period Number of stock options outstanding, Exercisable at end of period Weighted average exercise price, Exercisable at end of period Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise price Stock options outstanding Weighted average remaining contractual life Stock options exercisable StockOptionsValuationAssumptionsTable [Table] Expected volatility, minimum Expected volatility, maximum Risk-free interest, minimum Risk-free interest, maximum Dividend yield Expected terms (years) Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of outstanding warrants Exercise price Exercisable Through Issued shares Share price per share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Proceeds from Stock Options Exercised Agent fees and other offering expenses Placement agent fee Offering expense Sale of Stock, Consideration Received on Transaction Total gross proceeds Other offering expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Payments for Other Fees Agggregate number of options granted Proceeds from options Number of shares issued Total authorized shares Preferred stock, shares authorized Stock Issued During Period, Shares, Other Share Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Proceeds from exercise of PIOs Inducement transaction cost Unpaid amount Weighted-average exercise price per share, granted Additional number of stock options granted Compensation expenses Compensation percentage Annual bonus Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Common stock capital shares reserved for future issuance Aggregate intrinsic value of outstanding options Aggregate intrinsic value of exercisable options Weighted average grant date fair value of options granted Unrecognized compensation costs, net of expected forfeitures Unrecognized compensation weighted average period Diluted loss per share ResearchAndDevelopmentExpensesTable [Table] Payroll and related expenses Share-based compensation Materials and subcontractors Patents Rent Office and maintenance expenses Depreciation Other Less - grants Research and development expense GeneralAndAdministrativeExpensesTable [Table] Government fees Professional services Insurance Public and investor relations Travel Other General and administrative expenses Payroll and payroll related Materials and subcontractors Other segment items Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Long lived assets and operating lease right of use assets Number of operating segment Number of reportable segment Net operating loss carryforwards Operating lease liabilities Accrued vacation pay Advance payment from IIA Total deferred tax assets Less: valuation allowance Net deferred tax assets Operating leases, right-of-use assets Total deferred tax liabilities Total net deferred tax assets U.S. federal tax rate Us statutory tax rate, percentage Statutory tax rate difference between U.S. and Israel Statutory tax rate difference between U.S. and Israel, percentage Changes in valuation allowances Changes in valuation allowances, percentage Share-based compensation Share-based compensation, percentage Other adjustments Other Adjustments, percentage Effective tax rate Effective tax rate, percentage Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Corporate income tax rate Net operating loss carryforwards Operating loss carryforwards Subsequent Event [Table] Subsequent Event [Line Items] Employee benefits and share based compensation Special bonus Option granted Potential payment Issuance of common stock value relating to settlement agreement. Issuance of common stock under atthemarket offering program net of issuance costs. Stock issued during period value warrants exercised. At-the-Market Offering Program [Member] Interest income and unrealized gains from marketable securities net. Increase decrease in legal settlement and legal expenses received in cash. Increase decrease in legal settlement. Accrued bonus settled through grant of stock-option awards. Issuance of common stock shares relating to settlement agreement. Issuance of common stock shares under atthemarket offering program net of issuance costs. Stock issued during period shares warrants exercised. Schedule Of Property And Equipment Useful Lives [Table Text Block] Research Equipment and Software [Member] Furniture And Office Equipment [Member] Government grants. Accounting Pronouncements Not Yet Effective [Policy Text Block] Prepaid Expenses and Other Current Assets [Text Block] Bank guarantee issued. 2013 Through June 30, 2022 [Member] Israeli Innovation Authority [Member] Additional grant receivable. Repayment of government grants. CardioSert Ltd [Member] Net sales royalty percentage. Ministry of Economy [Member] Technion Research And Development Foundation Limited [Member] Offering costs. At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Placement fee percent. Gross proceeds from management fee percentage. Gross proceeds from cash fee percentage. Royalties percent. Device [Member] Integrated Product [Member] Securities Purchase Agreement [Member] Litigation Settlement [Member] Insurance recovery amount. CEO, Executives [Member] Certain Employees [Member] Agent fees and other offering expenses. Preferred Investment Option Exercise Inducement Offers Letter [Member] Series F Preferred Investment Options [Member] Series G Preferred Investment Options [Member] Series H Preferred Investment Options [Member] Series I Preferred Investment Options [Member] Placement Agent Preferred Investment Options [Member] Series A Preferred Investment Options [Member] Series E, G, H, I and Series F Preferred Investment Options [Member] Additional share based compensation arrangement by share based payment award options grants in period gross. Chief Executive Officer and Other Executives [Member] Advisors [Member] Annual bonus. Employees and Directors [Member] Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Exercise Price Five [Member] Warrant To Underwriters October 2022 [Member] Warrant To Underwriters May 2023 [Member] Warrant To Underwriters May 2023 One [Member] Warrant to Underwriters June 2023 [Member] Warrant to Underwriters June 2023 One [Member] Warrant Series E January 2024 [Member] Warrant to Underwriters January 2024 [Member] Warrant Series F June 2024 [Member] Warrant to Underwriters June 2024 [Member] Warrant To Underwriters January 2025 [Member] Warrant To Underwriters January 2025 One [Member] Warrant To Underwriters January 2025 Two [Member] Warrant to Underwriters February 2025 [Member] Warrant To Underwriters September 2025 [Member] Warrant To Underwriters September 2025 One [Member] Warrant To Underwriters September205 Two [Member] Warrant To Underwriters September2025 Three [Member] Warrant To Underwriters September 2025 Four [Member] Warrant To Underwriters September 2025 Five [Member] Warrant To Underwriters September 2025 Six [Member] Warrant To Underwriters September 2025 Seven [Member] Warrant To Underwriters September 2025 Eight [Member] Warrant to Underwriters September 2025 Nine [Member] Warrant Series J September 2025 [Member] Warrant Series J September 2025 One [Member] Class of warrant or righst month year from which warrants or rights exercisable. Executives and Certain Employees [Member] Office and maintenance expenses. Grants. General and Administrative Expenses [Text Block] Schedule of General and Administrative Expense [Table Text Block] The amount of expense provided in the period for government service fees. Amount of general and administrative expense related to public and investor relation. Payroll and payroll related. Materials and subcontractors. Schedule of Long Lived Assets and Operating Lease Right of Use Assets By Geographical Areas [Table Text Block] Long lived assets and operating lease right of use assets. US Tax Authority [Member] Pre 2017 [Member] Post 2017 [Member] Deferred tax assets operation lease liabilities. Deferred tax assets accrued vacation pay. Deferred tax assets advance payment. Deferred tax liabilities operating leases right of use assets. Stock issuance costs payable. Long Term Deposit [Policy Text Block] Series C Preferred Investment Options [Member] Series D Preferred Investment Options [Member] Existing Preferred Investment Options [Member] Inducement Investment Options [Member] The Letter Agreement [Member] Series J Preferred Investment Options [Member] Preferred Investment Options [Member] Second Closing [Member] Third Closing [Member] Inducement transaction cost. Unpaid amount. Wainwright [Member] Board [Member] 2020 Omnibus Performance Award Plan [Member] Executives [Member] Certain Employees and Certain Board Members [Member] Warrant Series J October 2025 Two [Member] Warrant Series J October 2025 One [Member] Potential payment. Proceeds from exercise of options. Income tax reconciliation income tax expenses benefit at federal statutory income tax rate. Chief Executive Officer and Executives and Certain Employees [Member] Location, Statement of Income, Balance [Axis] Research and Development Expenses [Member] Sales,General and Administrative Expenses [Member] Issuance costs not paid. Deferred issuance costs. Employees [Member] Useful Life, Lease Term [Member] Restricted Cash and Cash Equivalent, Noncurrent Assets Liabilities Equity, Attributable to Parent Liabilities and Equity Research and Development Expense Selling, General and Administrative Expense Operating Income (Loss) Shares, Outstanding InterestIncomeAndUnrealizedGainsFromMarketableSecuritiesNet Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Deposit Assets IncreaseDecreaseInLegalSettlementAndLegalExpensesReceivedInCash Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment Payments to Acquire Held-to-Maturity Securities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation ProceedsFromExerciseOfOptions Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Long Term Deposit [Policy Text Block] Share-Based Payment Arrangement [Policy Text Block] Marketable Securities, Policy [Policy Text Block] Lessee, Leases [Policy Text Block] Inventory, Policy [Policy Text Block] GovernmentGrants Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Operating Lease, Liability Gain (Loss) from Litigation Settlement Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Class of Warrant or Right, Exercise Price of Warrants or Rights Labor and Related Expense Cost, Direct Material Royalty Expense Other Research and Development Expense Office and maintenance expenses Depreciation Government fees Professional Fees General Insurance Expense Public and investor relations Travel and Entertainment Expense Other General and Administrative Expense General and Administrative Expense Segment Reporting, Other Segment Item, Amount Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance DeferredTaxLiabilitiesOperatingLeasesRightofUseAssets Deferred Tax Liabilities, Net Deferred Tax Assets, Net Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Income Tax Expense (Benefit) Effective Income Tax Rate Reconciliation, Percent Operating Loss Carryforwards